72 related articles for article (PubMed ID: 18409660)
1. Biomarker CCSA-2 may provide accurate blood test for colorectal cancer.
Oncology (Williston Park); 2008 Feb; 22(2):147. PubMed ID: 18409660
[No Abstract] [Full Text] [Related]
2. Serum p53 antibodies as an early detection marker in colorectal cancer.
Takeda A; Shimadai H; Iseki H; Saeki T; Koyama I
Hepatogastroenterology; 2007 Sep; 54(78):2 pages preceeding table of content. PubMed ID: 18019675
[No Abstract] [Full Text] [Related]
3. Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: a preliminary observation.
Xue G; Wang X; Yang Y; Liu D; Cheng Y; Zhou J; Cao Y
PLoS One; 2014; 9(4):e94252. PubMed ID: 24710115
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
[TBL] [Abstract][Full Text] [Related]
5. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
Leman ES; Schoen RE; Weissfeld JL; Cannon GW; Sokoll LJ; Chan DW; Getzenberg RH
Cancer Res; 2007 Jun; 67(12):5600-5. PubMed ID: 17575123
[TBL] [Abstract][Full Text] [Related]
6. NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer.
Briggman J; Genduso R; Camara C; Healy B; Shapiro K; Roos R; Merrifield S; Lifter J; Wu YJ; Elder E; Talamonti M
Anticancer Res; 1999; 19(4A):2411-4. PubMed ID: 10470167
[TBL] [Abstract][Full Text] [Related]
7. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
[TBL] [Abstract][Full Text] [Related]
8. [The possible approaches to prognosis in colorectal cancer].
Teploukhova IM; Vvedenskaia NA; Papish EA
Vopr Onkol; 1991; 37(6):651-6. PubMed ID: 1843140
[No Abstract] [Full Text] [Related]
9. [Early detection of cancer/testis mRNAs in tumor cells circulating in the peripheral blood of colorectal cancer patients].
Novikov DV; Belova TV; Plekhanova ES; Ianchenko OS; Novikov VV
Mol Biol (Mosk); 2012; 46(5):766-72. PubMed ID: 23156676
[TBL] [Abstract][Full Text] [Related]
10. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Grotowski M
Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
[TBL] [Abstract][Full Text] [Related]
11. [Serum sialyl-Tn antigen in colorectal cancer and its relationship to prognosis].
Yamaguchi A; Tukioka Y; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1992 Mar; 19(3):349-53. PubMed ID: 1543361
[TBL] [Abstract][Full Text] [Related]
12. Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?
Eskelinen M; Pasanen P; Janatuinen E; Pettersson N; Linnane A; Alhava E
Anticancer Res; 1995; 15(5B):2351-6. PubMed ID: 8572651
[TBL] [Abstract][Full Text] [Related]
13. Prostatic specific antigen in prostate cancer.
Wozniak-Petrofsky J
Urol Nurs; 1992 Sep; 12(3):104-5. PubMed ID: 1382317
[No Abstract] [Full Text] [Related]
14. Biotechnology. Researcher, two universities sued over validity of prostate cancer test.
Kaiser J
Science; 2009 Sep; 325(5947):1484. PubMed ID: 19762612
[No Abstract] [Full Text] [Related]
15. Nuclear non-histone protein p36 associated with colorectal tumours.
Kiliańska ZM; Szymczyk P; Krajewska WM; Jakubik J; Błoński J; Berner J; Robak T
Cytobios; 2001; 106 Suppl 1():35-42. PubMed ID: 11534827
[TBL] [Abstract][Full Text] [Related]
16. Measurement of prostate-specific antigen as a screening test for prostate cancer.
N Engl J Med; 1991 Sep; 325(13):963-5. PubMed ID: 1715514
[No Abstract] [Full Text] [Related]
17. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor markers in breast cancer.
Tondini C; Hayes DF; Kufe DW
Hematol Oncol Clin North Am; 1989 Dec; 3(4):653-74. PubMed ID: 2691493
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma antigen as a biomarker for penile cancer.
Kommu S; Hadway P; Watkin N
BJU Int; 2005 Mar; 95(4):478-9. PubMed ID: 15705062
[No Abstract] [Full Text] [Related]
20. Plasma microRNAs: a potential biomarker for colorectal cancer?
Schetter AJ; Harris CC
Gut; 2009 Oct; 58(10):1318-9. PubMed ID: 19749133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
